Skip to main content

Table 1 Demographic and clinical characteristics of COVID-19 patients, 8/25/2020 to 5/8/2021

From: Seasonal COVID-19 surge related hospital volumes and case fatality rates

 

Overall (n = 7388)

Pre-surge period (n = 536)

Surge period (n = 6372)

Post-surge period (n = 480)

p-value

Average daily cases, mean (SD)

28.7 (37.5)

7.1 ( 3.7)

59.6 (41.6)

6.4 ( 3.1)

 < 0.001

Demographic characteristics

 Age, mean (SD), years

52.76 (19.60)

50.26 (19.78)

53.29 (19.53)

48.48 (19.52)

 < 0.001

 Male sex, n (%)

3529 (47.8)

260 (48.5)

3054 (47.9)

215 (44.8)

0.389

Race/ethnicity, n (%)

  Asian

624 (8.4)

31 (5.8)

564 (8.9)

29 (6.0)

 < 0.001

  Hispanic/Latinx

2423 (32.8)

158 (29.5)

2136 (33.5)

129 (26.9)

  Non-Hispanic Black

1212 (16.4)

97 (18.1)

1034 (16.2)

81 (16.9)

  Non-Hispanic White

2416 (32.7)

193 (36.0)

2031 (31.9)

192 (40.0)

  Other

368 (5.0)

21 (3.9)

324 (5.1)

23 (4.8)

Clinical characteristics

 Elixhauser comorbidity scorea, mean ± SD

7.44 (11.84)

6.31 (10.24)

7.50 (11.95)

7.82 (11.98)

0.060

 Obesity, n (%)

1697 (23.0)

109 (20.3)

1498 (23.5)

90 (18.8)

0.019

 Hypertension, n (%)

3001 (40.6)

176 (32.8)

2648 (41.6)

177 (36.9)

 < 0.001

 Diabetes mellitus, n (%)

1804 (24.4)

105 (19.6)

1597 (25.1)

102 (21.2)

0.004

 Prior myocardial infarction or heart failure, n (%)

1230 (16.6)

70 (13.1)

1073 (16.8)

87 (18.1)

0.052

 Prior COPD or asthma, n (%)

1326 (17.9)

78 (14.6)

1174 (18.4)

74 (15.4)

0.026

  1. COPD, chronic obstructive pulmonary disease; SD, standard deviation
  2. aElixhauser comorbidity score calculated using the van Walraven method